Commissioner Hamburg recently presented the new FDA.gov website (1-see the video).
The new website is easier to read and navigate around due to changes in space methods and an improved, helpful organization. It's a better guide and the space and content work well together.
Also, the new FDA Transparency Blog shows q's posted along with news items and notices-- readers' responses to FDA posts are steadily being posted and shared by many in the know. The comments make some good points. One comment posted on the blog indicated that a window can be transparent in order to see what is going on inside but it is more important to understand the meaning of what one sees and to establish trust about what you are seeing. (**)
The purpose of this Transparency Blog is to discuss various ways in which the [FDA] could provide information to the public about what FDA is doing, the bases for FDA’s decisions, and the processes used to make agency decisions. The blog is expected to run for the next 6 months (June through November 2009)....FDA provides blog posts and updates over the coming weeks asking for your feedback on these topics.
FDA established a Task Force to develop recommendations for making FDA processes and decision making more transparent to the public. The Task Force will continue to use your feedback to inform its work during the next six months. It's a good opportunity to participate. See their Comment Policy.(3)
(1)http://www.fda.gov/default.htm
(2) FDA Transparency Task Force
-- View Public Meeting
-- Participate in Blog
http://fdatransparencyblog.fda.gov/2009/06/index.html
(3)http://fdatransparencyblog.fda.gov/comment-policy.html
**Or something to that effect-see the FDA Transparency Blog comments under the 6/21 FDA q' post, comment by Melissa Langone, PhD, ARNP, CNS.